OncoCyte Corp
NASDAQ:OCX

Watchlist Manager
OncoCyte Corp Logo
OncoCyte Corp
NASDAQ:OCX
Watchlist
Price: 3.16 USD -1.25% Market Closed
Market Cap: 90.4m USD

Wall Street
Price Targets

OCX Price Targets Summary
OncoCyte Corp

There are no price targets for OCX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
OncoCyte Corp Competitors:
Price Targets
NRIX
Nurix Therapeutics Inc
54% Upside
600201
Jinyu Bio-Technology Co Ltd
40% Downside
CRNX
Crinetics Pharmaceuticals Inc
81% Upside
688363
Bloomage Biotechnology Corp Ltd
10% Upside
BCRX
BioCryst Pharmaceuticals Inc
189% Upside
ATX
Amplia Therapeutics Ltd
257% Upside
INCY
Incyte Corp
1% Downside
COV
Covalon Technologies Ltd
121% Upside

Revenue
Forecast

Revenue Estimate
OncoCyte Corp

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 92%.

N/A
Past Growth
92%
Estimated Growth
Estimates Accuracy
-46%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OCX's stock price target?
Not Available

OCX doesn't have any price targets made by Wall Street professionals.

What is OncoCyte Corp's Revenue forecast?
Projected CAGR
92%

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 92%.

Back to Top